Adaptive Biotechnologies Corporation (ADPT) Ownership

$11.82

$0.26 (-2.15%)
Last update: 04:00 PM EST
Day's range
$11.66
Day's range
$12.05

Adaptive Biotechnologies Corporation Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VIKING GLOBAL INVESTORS LP 05/15/2025 29.99 M $222.85 M   0.00% 20.10%
RUBRIC CAPITAL MANAGEMENT LP 05/14/2025 13.12 M $97.47 M   -10.15% 8.79%
BLACKROCK, INC. 05/02/2025 12.23 M $90.87 M   0.90% 8.20%
VANGUARD GROUP INC 05/09/2025 11.14 M $82.80 M   4.00% 7.47%
ARK INVESTMENT MANAGEMENT LLC 05/07/2025 7.73 M $57.45 M   -17.95% 5.18%
AMERIPRISE FINANCIAL INC 05/14/2025 6.64 M $49.35 M   801.63% 4.45%
SUMITOMO MITSUI TRUST HOLDINGS, INC. 04/25/2025 6.09 M $45.22 M   -10.94% 4.08%
NIKKO ASSET MANAGEMENT AMERICAS, INC. 05/07/2025 6.09 M $45.16 M   -10.94% 4.08%
BRAIDWELL LP 05/15/2025 4.80 M $35.69 M   100.00% 3.22%
MILLENNIUM MANAGEMENT LLC 05/15/2025 3.00 M $22.26 M   -52.40% 2.01%
ARISTOTLE ATLANTIC PARTNERS, LLC 05/15/2025 2.94 M $21.85 M   1.89% 1.97%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 2.78 M $20.67 M   3.59% 1.86%
STATE STREET CORP 05/15/2025 2.69 M $19.98 M   -1.48% 1.80%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 05/02/2025 2.31 M $17.14 M   -31.58% 1.55%
DRIEHAUS CAPITAL MANAGEMENT LLC 05/15/2025 2.15 M $15.99 M   154.36% 1.44%
BLUE WATER LIFE SCIENCE ADVISORS, LP 05/15/2025 2.15 M $15.94 M   0.00% 1.44%
VOYA INVESTMENT MANAGEMENT LLC 06/18/2025 2.01 M $14.90 M   -17.41% 1.34%
GOLDMAN SACHS GROUP INC 06/27/2025 2.01 M $14.90 M   -10.40% 1.34%
VICTORY CAPITAL MANAGEMENT INC 05/02/2025 1.76 M $13.11 M   9,892.22% 1.18%
BANK OF AMERICA CORP /DE/ 05/15/2025 1.47 M $10.93 M   510.61% 0.99%
DIMENSIONAL FUND ADVISORS LP 05/13/2025 1.42 M $10.59 M   -11.23% 0.95%
05/12/2025 1.30 M $9.62 M   100.00% 0.87%
KENNEDY CAPITAL MANAGEMENT LLC 05/13/2025 1.27 M $9.43 M   100.00% 0.85%
ABRDN PLC 05/13/2025 1.20 M $8.90 M   19.28% 0.80%
MORGAN STANLEY 05/15/2025 1.13 M $8.36 M   -5.74% 0.75%
PIER CAPITAL, LLC 05/13/2025 1.10 M $8.15 M   -13.88% 0.74%
JPMORGAN CHASE & CO 05/12/2025 1.08 M $8.06 M   64.47% 0.73%
NORTHERN TRUST CORP 05/13/2025 1.05 M $7.83 M   -3.69% 0.71%
LORD, ABBETT & CO. LLC 05/13/2025 1.03 M $7.63 M   100.00% 0.69%
PERCEPTIVE ADVISORS LLC 05/15/2025 930.97 K $6.92 M   100.00% 0.62%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 922.74 K $6.86 M   -3.54% 0.62%
PRUDENTIAL FINANCIAL INC 05/13/2025 637.99 K $4.74 M   32.37% 0.43%
ESSEX INVESTMENT MANAGEMENT CO LLC 05/07/2025 621.71 K $4.62 M   -0.66% 0.42%
DEUTSCHE BANK AG\ 05/09/2025 618.18 K $4.59 M   -1.97% 0.41%
05/15/2025 611.64 K $4.54 M   100.00% 0.41%
CLEARLINE CAPITAL LP 05/16/2025 586.38 K $4.36 M   -0.07% 0.39%
INVESCO LTD. 05/12/2025 552.53 K $4.11 M   218.29% 0.37%
POLAR ASSET MANAGEMENT PARTNERS INC. 05/15/2025 527.96 K $3.92 M   100.00% 0.35%
TUDOR INVESTMENT CORP ET AL 05/15/2025 514.16 K $3.82 M   12.14% 0.34%
CERITY PARTNERS LLC 04/30/2025 457.02 K $3.40 M   -4.48% 0.31%
CINCTIVE CAPITAL MANAGEMENT LP 05/15/2025 376.74 K $2.80 M   56.12% 0.25%
BANK OF NEW YORK MELLON CORP 04/29/2025 358.07 K $2.66 M   -1.60% 0.24%
PDT PARTNERS, LLC 05/15/2025 344.98 K $2.56 M   9.07% 0.23%
AQR CAPITAL MANAGEMENT LLC 05/15/2025 310.27 K $2.26 M   45.79% 0.21%
FMR LLC 05/12/2025 288.47 K $2.14 M   12.80% 0.19%
PRINCIPAL FINANCIAL GROUP INC 04/28/2025 285.14 K $2.12 M   98.78% 0.19%
TREXQUANT INVESTMENT LP 05/14/2025 284.78 K $2.12 M   53.22% 0.19%
UBS GROUP AG 05/13/2025 275.62 K $2.05 M   -30.62% 0.18%
LEGAL & GENERAL GROUP PLC 05/15/2025 205.19 K $1.52 M   88.89% 0.14%
BARCLAYS PLC 05/15/2025 203.97 K $1.52 M   -23.34% 0.14%

Adaptive Biotechnologies Corporation institutional Ownership - FAQ's

During the previous two years, 276 institutional investors and hedge funds held shares of Adaptive Biotechnologies Corporation. The most heavily invested institutionals were:

Rise Advisors, LLC: 0

VIKING GLOBAL INVESTORS LP: 29.99 M

Rubric Capital Management LP: 13.12 M

BlackRock, Inc.: 12.23 M

VANGUARD GROUP INC: 11.14 M

ARK Investment Management LLC: 7.73 M

101.07% of Adaptive Biotechnologies Corporation stock is owned by institutional investors.

Institutional investors have bought a total of 165.85 M shares in the last 24 months. This purchase volume represents approximately $1.97 B in transactions.